Back to Search
Start Over
252P Does the introduction of CDK4/6 inhibitors (CDKi) in first-line treatment of metastatic breast cancer (MBC) increase medical oncology workload?
- Source :
-
Annals of Oncology . 2021 Supplement 5, Vol. 32, pS470-S470. 1p. - Publication Year :
- 2021
- Subjects :
- *METASTATIC breast cancer
*ONCOLOGY
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152688883
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.08.535